Inclusion Criteria:

1. Aged 18 to 60 years;

2. Those who have been recently diagnosed with moderate-to- severe OSAHS (AHI ≥ 15
beats/h) and who refuse or cannot tolerate the counter-adverse effects and refuse
CPAP therapy after conventional medical advice;

3. Those who have not undergone any physical therapy;

4. Have some communication and comprehension skills and can use a smart phone;

5. Signed informed consent.

Exclusion Criteria:

1. BMI > 35kg/m2;

2. Patients with central and mixed sleep apnea;

3. Those who use sleep aids (including benzodiazepines and non-benzodiazepine
sedative-hypnotics, anxiolytics with sleep-aiding effects, antidepressants,
antipsychotics) and/or nutritional supplements;

4. Those suffering from acute myocardial infarction, acute tachyarrhythmia, pulmonary
edema, severe aortic stenosis and other acute cardiovascular diseases;

5. Those with severe respiratory diseases such as asthma, chronic obstructive pulmonary
disease (COPD), lung volume limitation (due to obesity, pregnancy, or spinal
deformity), or cystic fibrosis, pneumothorax, or alveoli;

6. Those with hypothyroidism;

7. Those with severe ENT disorders such as severe upper airway obstruction (complete
nasal congestion, tonsil grade III/IV), tongue-tie (Marchesani's protocol), motor
symptoms limiting the tongue, antecedent or presence of temporomandibular joint
disorders, and severe craniofacial injuries;

8. Those with inflammation-related systemic diseases (e.g., arthritis, tuberculosis,
vasculitis, lupus);

9. Those who suffer from neuromuscular diseases (e.g., Duchenne muscular dystrophy) or
diseases of the skeleton that prevent them from performing parallel movements due to
exercise;

10. Those who smoke and drink alcohol;

11. Those who have had other sleep apnea treatments within 6 months (e.g., surgical
procedures, MAD or CPAP treatments) that may affect the study results;

12. Ongoing clinical trials of drugs or devices in which they are participating;

13. Refusal to sign the informed consent form.